Menu Search
Equities

Health Catalyst Inc

2YP:DUS

Health Catalyst Inc

Actions
  • Price (EUR)7.75
  • Today's Change0.600 / 8.39%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company’s solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.

  • Revenue in USD (TTM)302.06m
  • Net income in USD-79.14m
  • Incorporated2011
  • Employees728.00
  • Location
    Health Catalyst Inc10897 SOUTH RIVER FRONT PARKWAY, #300SOUTH JORDAN 84095United StatesUSA
  • Phone+1 (801) 708-6800
  • Fax+1 (302) 655-5049
  • Websitehttps://www.healthcatalyst.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		HCAT:NSQ since
announced		Transaction
value
Intraprise Health LLCAnnounced06 Nov 202406 Nov 2024Announced4.77%17.08m
Lumeon LtdDeal completed08 Aug 202408 Aug 2024Deal completed48.36%--
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.